Success Metrics

Active Trials
3(50%)

Phase Distribution

Ph phase_2
1
17%
Ph not_applicable
1
17%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution2 total trials
Phase 2Efficacy & side effects
1(50.0%)
N/ANon-phased studies
1(50.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

3

trials recruiting

Total Trials

6

all time

Status Distribution
Active(5)
Terminated(1)

Detailed Status

Recruiting2
Not yet recruiting2
Withdrawn1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
3
Success Rate
N/A
Most Advanced
Phase 2

Trials by Phase

Phase 21 (50.0%)
N/A1 (50.0%)

Trials by Status

recruiting233%
not_yet_recruiting233%
withdrawn117%
active_not_recruiting117%

Recent Activity

3 active trials
Showing 5 of 6
not_yet_recruiting

Comparative Analysis of SUV Measurements Using Different Correction Methods in Oncological PET/CT Imaging.

NCT07306975
recruiting

Using Novel Imaging to Rethink Diagnostic and Treatment Strategies for Polymyalgia Rheumatica

NCT07010484
not_yet_recruiting

Volumetric Parameter of 18F-FDG PET/CT in Characterizing Thyroid Incidentalomas

NCT07163806
recruitingnot_applicable

Artificial Intelligence in Molecular Imaging: Predicting Parkinson's Risk in REM Sleep Behavior Disorder

NCT06629207
active_not_recruiting

BIOMARKER and IMAGING CHARACTERISATION of INFLAMMATORY ATHEROMA in PATIENTS RECEIVING IMMUNOTHERAPY and ANGIOGENESIS INHIBITORS

NCT06597045
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT07306975

Comparative Analysis of SUV Measurements Using Different Correction Methods in Oncological PET/CT Imaging.

Not Yet Recruiting
NCT07010484

Using Novel Imaging to Rethink Diagnostic and Treatment Strategies for Polymyalgia Rheumatica

Recruiting
NCT07163806

Volumetric Parameter of 18F-FDG PET/CT in Characterizing Thyroid Incidentalomas

Not Yet Recruiting
NCT06629207Not Applicable

Artificial Intelligence in Molecular Imaging: Predicting Parkinson's Risk in REM Sleep Behavior Disorder

Recruiting
NCT06597045

BIOMARKER and IMAGING CHARACTERISATION of INFLAMMATORY ATHEROMA in PATIENTS RECEIVING IMMUNOTHERAPY and ANGIOGENESIS INHIBITORS

Active Not Recruiting
NCT01471418Phase 2

The Use of PET/CT to Evaluate Synovitis in the Temporomandibular Joint (TMJ)

Withdrawn

All 6 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
6